Kardigan, Inc.
KARDFigures shown here come from public SEC filings. Dates beside each section show the available history.
SEC filings supply these figures; updates after the dates shown are not included. No annual financial history is available for this company. The latest insider filing shown is dated Jun 24, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-22 | HRTG GPE, LLC · 10% owner | Common Stock | P — Open market or private purchase | +3,125,000 | 16.00 | SEC filing |
| 2026-06-22 | CRANDELL KEITH · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,250,000 | 16.00 | SEC filing |
| 2026-06-22 | BERNS PAUL L · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,250,000 | 16.00 | SEC filing |
Showing 3 of 3 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | BERNS PAUL L · Director, 10% owner | Common Stock | C — Conversion of derivative security | +13,792,035 | SEC filing |
| 2026-06-17 | ARCH Venture Partners XIII, LLC · Director, 10% owner | Series B Preferred Stock | C — Conversion of derivative security | −1,204,000 | SEC filing |
| 2026-06-17 | HRTG GPE, LLC · 10% owner | Series B-1 Redeemable Convertible Preferred Stock | C — Conversion of derivative security | −1,474,368 | SEC filing |
| 2026-06-17 | GIANAKAKOS ANASTASIOS · President & CEO | Series A Preferred Stock | C — Conversion of derivative security | −25,742 | SEC filing |
| 2026-06-17 | HRTG GPE, LLC · 10% owner | Series A Redeemable Convertible Preferred Stock | C — Conversion of derivative security | −3,861,440 | SEC filing |
| 2026-06-17 | BERNS PAUL L · Director, 10% owner | Series A Preferred Stock | C — Conversion of derivative security | −5,148,587 | SEC filing |
| 2026-06-17 | ARCH Venture Partners XIII, LLC · Director, 10% owner | Series B-1 Preferred Stock | C — Conversion of derivative security | −2,306,401 | SEC filing |
| 2026-06-17 | Edelberg Jay · Chief Medical Officer | Common Stock | C — Conversion of derivative security | +97,587 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.